Latest Partnerships News

Osteopore Limited has drawn down A$2 million from the first tranche of its redeemable convertible notes, using the proceeds to repay existing loans and support ongoing business activities.

Bulletin Resources has received the final $0.8 million payment from Ramelius Resources for the partial sale of tenure at its Lake Rebecca Gold Project, completing a transaction that has injected nearly $4.8 million into the company since 2021.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Patriot Battery Metals reported a Q3 net loss of $2.23 million and a nine-month loss of $5.60 million, reflecting heavy investment in its flagship Shaakichiuwaanaan lithium project. A strategic $69 million private placement with Volkswagen post-quarter end underscores growing industry confidence.

Macarthur Minerals Limited reported a comprehensive loss of AUD 252,771 for Q4 2024, marking a sharp reversal from the prior year's profit. The company is navigating reduced exploration spending and strategic asset sales while facing ongoing funding challenges.

Scorpion Minerals Limited has had its trading suspension lifted following an announcement about a potential joint venture and capital raising, signaling renewed market activity.

E79 Gold Mines has entered a strategic earn-in and joint venture agreement with Scorpion Minerals over the Jungar Flats Project, enabling E79 to reduce expenditure while focusing on promising gold and copper-gold projects elsewhere.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

Mirvac's 1H25 results reveal a modest decline in EBIT and operating profit, yet the company signals strong growth prospects fueled by residential sales momentum, sustainable development, and strategic capital partnering.